In another study conducted by Knowles et al., the 124I- and 89Zr-labeled prostate stem cell antigen (anti-PSCA) A11 minibodies were evaluated and compared for quantitative immuno-PET imaging of prostate cancer. This evidence concerns the gene PSCA and prostate cancer.